×

Health / Health Care

Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study

Published Apr 27 2021 at 12:35 PM GMT

Seeking Alpha @seekingalpha.com

Add to Collections
Report Post

Continue reading at seekingalpha.com

Key
Points

Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study.

Credit

Tags

Continue reading at seekingalpha.com

Posted in Health, Health Care

Stats

Published Apr 27, 2021 12:35 PM GMT